Discovery Programs
R&D Pipeline
Gubra has a robust R&D pipeline focused on target discovery and peptide drug development. We specialize in metabolic, fibrotic, and inflammatory diseases, where we have deep scientific expertise.
Why Gubra?
- Innovative, data-driven approach
- Expert guidance in targets and disease areas
- High-quality data with integrity, speed, and flexibility
- Professional and agile project organization
Consult with Louise S. Dalbøge
Chief Science Officer
Choose the right, trustworthy discovery partner.
Balanced portfolio of internal & partnered programs
Gubra’s R&D Pipeline
Gubra’s R&D pipeline features a balanced mix of partnered programs and internal projects, available for partnering now or at a later stage. Contact us to learn more.
“
Our scientific expertise, combined with AI-driven platforms, is the foundation of our strong pipeline.
We combine AI and machine learning with cutting-edge science to accelerate our programs. Our agile approach, coupled with complete in-house capabilities, ensures speed and high-quality data.
Niels Vrang (co-founder)
Key figures
5
Active Partnerships
- Current collaboration partners: Boehringer Ingelheim and Hemab.
- A long-term trusted alliance partner
4
Clinical Development
- Four projects in clinical development phase
- Two projects in Phase I
6+
Open Projects
- A diverse portfolio of internal projects
- Ready to be partnered now or later
Related pages
For further information
Contact us
Gubra
Hørsholm Kongevej 11B
2970 Hørsholm
Denmark
+45 3152 2650